Globe Life (GL) – Investment Analysts’ Recent Ratings Updates

Globe Life (NYSE: GL) has recently received a number of price target changes and ratings updates:

• 7/21/2026 – Globe Life had its price target raised by JPMorgan Chase & Co. from $181.00 to $201.00. They now have an “overweight” rating on the stock.
• 7/20/2026 – Globe Life was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 7/15/2026 – Globe Life had its price target raised by Piper Sandler from $175.00 to $200.00. They now have an “overweight” rating on the stock.
• 7/13/2026 – Globe Life had its price target raised by Keefe, Bruyette & Woods from $180.00 to $192.00. They now have an “outperform” rating on the stock.
• 7/10/2026 – Globe Life had its price target raised by Jefferies Financial Group Inc. from $147.00 to $166.00. They now have a “hold” rating on the stock.
• 7/9/2026 – Globe Life had its price target raised by Wells Fargo & Company from $172.00 to $193.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – Globe Life had its price target raised by Morgan Stanley from $181.00 to $208.00. They now have an “overweight” rating on the stock.
• 6/23/2026 – Globe Life had its price target raised by TD Cowen from $199.00 to $215.00. They now have a “buy” rating on the stock.
• 5/26/2026 – Globe Life had its price target raised by Piper Sandler from $167.00 to $175.00. They now have an “overweight” rating on the stock.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.7%. Globe Life’s payout ratio is 9.13%.

Insiders Place Their Bets

In related news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This represents a 33.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO James Matthew Darden sold 4,663 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at approximately $8,994,439.88. This represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 124,187 shares of company stock valued at $19,529,414. 2.11% of the stock is currently owned by company insiders.

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.